Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07GLX
|
|||
| Former ID |
DIB013170
|
|||
| Drug Name |
CNS-1531
|
|||
| Indication | Nervous system disease [ICD-11: 8A00-8E7Z; ICD-10: G64, G90.0] | Terminated | [1] | |
| Company |
CeNeS Pharmaceuticals Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | N-methyl-D-aspartate receptor (NMDAR) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001975) | |||
| REF 2 | WO patent application no. 2009,0164,86, Use of nmda receptor antagonists for treatment of urologic tumors. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.